Mana.bio

AI-based Programmable Drug Delivery

Startup

Mana.bio is a Haifa-based startup in the Health Tech & Life Sciences sector, established in 2021. AI-based Programmable Drug Delivery. The company has raised a total of $24.5M across 2 funding rounds, currently at the Seed stage. Mana.bio was founded by Yogev Debbi and Roy Nevo. Key investors include LionBird, Technion Research & Development Foundation, Base4 Capital, among 5 total investors. The company has 11-50 employees. Core technologies: Artificial Intelligence, Machine Learning.

With $24.5M in total funding, Mana.bio is a Seed-stage company operating in Health Tech & Life Sciences. The company follows a B2B business model. Product stage: R&D.

$24.5M
Raised
2
Rounds
5
Investors
2
Team
2021
Founded
Sector & Technology
Health Tech & Life SciencesPharma & Medical BiotechnologyDrug DeliveryArtificial IntelligenceMachine Learning
At a Glance
Investors

5 investors total

Founders
In the News

4 articles covered by sources including www.prnewswire.com, www.calcalist.co.il, endpts.com.

www.prnewswire.com · Sep 17, 2025
/PRNewswire/ -- Mana.bio, a biotechnology company pioneering the intersection of artificial intelligence and RNA delivery, today announced the launch of Mina™,...
Read article ↗
Frequently Asked Questions
What does Mana.bio do?

Mana.bio specializes in AI-based drug-delivery solutions, with a focus on gene therapy. The companys technology integrates machine learning and nanotechnology for the development of drug-delivery systems. Mana.bio has created a platform for lipid nanoparticle development for oligonucleotide therapies, including mRNA-based therapeutics, vaccines, and gene therapy. The technology is powered by an integration of machine learning and nanotechnology in order to identify formulations of lipid nanoparticles drug delivery systems.

How much funding has Mana.bio raised?

Mana.bio has raised $24.5M in total funding across 2 rounds. The company is currently at the Seed stage. Key investors include LionBird, Technion Research & Development Foundation, Base4 Capital.

Who founded Mana.bio?

Mana.bio was founded in 2021 by Yogev Debbi (Co-founder & CEO), Roy Nevo (Co-founder & CTO).

What sector is Mana.bio in?

Mana.bio operates in Health Tech & Life Sciences, Pharma & Medical Biotechnology, Drug Delivery, with core technologies in Artificial Intelligence, Machine Learning. Target customers: Healthcare & Life Sciences, Life Sciences, Biotechnology.

Where is Mana.bio located?

Mana.bio is based in Haifa, Israel, Center District,North District.

View Full Profile Classic View Website ↗